INS.L Regulatory News (INS)

Instem plc("Instem")

Investor Teach-in

Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, announces it will be holding a teach-in for investors and analysts on Tuesday, 28th March 2017.

The event will be held in the Black Bar, upstairs at Rocket Bar, 6 Adams Court, Old Broad Street, London EC2N 1DX from 5pm for a 5.15pm start.

A presentation will be given by the Instem management team, CEO, Phil Reason, and CFO, Nigel Goldsmith, for approximately 45 minutes, at which point there will be an opportunity for questions. The presentation will include an overview of the Company and an outline of their strategy to deliver value for shareholders. No new material financial information will be disclosed. This will be followed by light refreshments and an opportunity to network.

To register for the event, please email instem@walbrookpr.com or call the Walbrook PR team below.

For further information, please contact:

About Instem

Instem is a leading supplier of IT applications and services to the early development healthcare market delivering compelling solutions for data collection, analysis and regulatory submissions management. Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.

Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information. Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India. To learn more about Instem solutions and its mission, please visit www.instem.com